Literature DB >> 1739619

Inactivation of p53 gene in human and murine osteosarcoma cells.

N Chandar1, B Billig, J McMaster, J Novak.   

Abstract

We examined structure and expression of the p53 and Rb genes in a C3HOS transplantable mouse model of osteosarcoma. The results were compared to analogous studies conducted with five human osteosarcoma cell lines. The p53 gene was found rearranged in the mouse tumour. The rearrangement mapped to the first intron region of the p53 gene and as a result, no p53 expression could be detected in C3HOS tumours. Using p53 genomic probes, we have detected the same rearrangement in the original radiation-induced tumour and the various clones that were isolated from it. Deletion and rearrangement of the p53 gene were also found in three out of five of the human osteosarcoma cell lines (MG-63, G-292, Saos-2). No p53 expression could be detected in these three cell lines. In the affected human osteosarcoma cell lines, the rearrangement involved the first intron region. In addition, the mouse tumor was analysed for structural and expression changes in the Rb and the c-myc genes. Normal expression of both genes were detected in the murine tumour. Only one (Saos-2) human osteosarcoma cell line exhibited gross structural alteration in the retinoblastoma gene. The results suggest that the inactivation of p53 may be an important step in the development of osteosarcomas, and that a rearrangement affecting the first intron is common in osteosarcomas.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1739619      PMCID: PMC1977714          DOI: 10.1038/bjc.1992.43

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  39 in total

1.  Familial osteosarcoma associated with 13;14 chromosomal rearrangement.

Authors:  P A Gilman; N Wang; S F Fan; J Reede; A Khan; B G Leventhal
Journal:  Cancer Genet Cytogenet       Date:  1985-06

2.  Participation of p53 cellular tumour antigen in transformation of normal embryonic cells.

Authors:  D Eliyahu; A Raz; P Gruss; D Givol; M Oren
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

3.  Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus.

Authors:  M Mowat; A Cheng; N Kimura; A Bernstein; S Benchimol
Journal:  Nature       Date:  1985 Apr 18-24       Impact factor: 49.962

4.  Analysis of ras genes and linked viral sequences in rat hepatocarcinogenesis.

Authors:  N Chandar; B Lombardi; W Schulz; J Locker
Journal:  Am J Pathol       Date:  1987-11       Impact factor: 4.307

5.  Inactivation of the cellular p53 gene is a common feature of Friend virus-induced erythroleukemia: relationship of inactivation to dominant transforming alleles.

Authors:  D G Munroe; J W Peacock; S Benchimol
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

6.  Mechanisms of p53 loss in human sarcomas.

Authors:  L M Mulligan; G J Matlashewski; H J Scrable; W K Cavenee
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

7.  Amplification and rearrangement of c-myc in radiation-induced murine osteosarcomas.

Authors:  S A Sturm; P G Strauss; S Adolph; H Hameister; V Erfle
Journal:  Cancer Res       Date:  1990-07-01       Impact factor: 12.701

8.  Inactivation of p53 gene expression by an insertion of Moloney murine leukemia virus-like DNA sequences.

Authors:  D Wolf; V Rotter
Journal:  Mol Cell Biol       Date:  1984-07       Impact factor: 4.272

9.  Human retinoblastoma susceptibility gene: cloning, identification, and sequence.

Authors:  W H Lee; R Bookstein; F Hong; L J Young; J Y Shew; E Y Lee
Journal:  Science       Date:  1987-03-13       Impact factor: 47.728

10.  Expression of protooncogenes in murine osteosarcomas.

Authors:  A Schön; L Michiels; M Janowski; J Merregaert; V Erfle
Journal:  Int J Cancer       Date:  1986-07-15       Impact factor: 7.396

View more
  41 in total

1.  p53-Independent and -dependent requirements for E1B-55K in adenovirus type 5 replication.

Authors:  J N Harada; A J Berk
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Apoptosis induced by the nuclear death domain protein p84N5 is inhibited by association with Rb protein.

Authors:  J Doostzadeh-Cizeron; R Evans; S Yin; D W Goodrich
Journal:  Mol Biol Cell       Date:  1999-10       Impact factor: 4.138

3.  Functional p53 chimeras containing the Epstein-Barr virus Gly-Ala repeat are protected from Mdm2- and HPV-E6-induced proteolysis.

Authors:  Stijn Heessen; Ainars Leonchiks; Natalia Issaeva; Anatoly Sharipo; Galina Selivanova; Maria G Masucci; Nico P Dantuma
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

4.  The history of p53. A perfect example of the drawbacks of scientific paradigms.

Authors:  Thierry Soussi
Journal:  EMBO Rep       Date:  2010-10-08       Impact factor: 8.807

5.  Expression of a mutant p193/CUL7 molecule confers resistance to MG132- and etoposide-induced apoptosis independent of p53 or Parc binding.

Authors:  Joshua D Dowell; Shih-Chong Tsai; Dora C Dias-Santagata; Hidehiro Nakajima; Zhuo Wang; Wuqiang Zhu; Loren J Field
Journal:  Biochim Biophys Acta       Date:  2006-12-15

6.  Cell-type-dependent activity of the ubiquitous transcription factor USF in cellular proliferation and transcriptional activation.

Authors:  Y Qyang; X Luo; T Lu; P M Ismail; D Krylov; C Vinson; M Sawadogo
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

7.  Adenovirus E4orf6 oncoprotein modulates the function of the p53-related protein, p73.

Authors:  F Higashino; J M Pipas; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

8.  Transcriptional activation by the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen is facilitated by an N-terminal chromatin-binding motif.

Authors:  Lai-Yee Wong; Gerald A Matchett; Angus C Wilson
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 9.  Osteosarcoma development and stem cell differentiation.

Authors:  Ni Tang; Wen-Xin Song; Jinyong Luo; Rex C Haydon; Tong-Chuan He
Journal:  Clin Orthop Relat Res       Date:  2008-06-18       Impact factor: 4.176

10.  Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells.

Authors:  B Song; Y Wang; Y Xi; K Kudo; S Bruheim; G I Botchkina; E Gavin; Y Wan; A Formentini; M Kornmann; O Fodstad; J Ju
Journal:  Oncogene       Date:  2009-09-07       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.